AU2001295915A1 - Method of forming polypeptide particles - Google Patents

Method of forming polypeptide particles

Info

Publication number
AU2001295915A1
AU2001295915A1 AU2001295915A AU9591501A AU2001295915A1 AU 2001295915 A1 AU2001295915 A1 AU 2001295915A1 AU 2001295915 A AU2001295915 A AU 2001295915A AU 9591501 A AU9591501 A AU 9591501A AU 2001295915 A1 AU2001295915 A1 AU 2001295915A1
Authority
AU
Australia
Prior art keywords
forming polypeptide
polypeptide particles
particles
forming
polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001295915A
Inventor
Akihiro Matsumoto
Takahiro Morita
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tanabe Seiyaku Co Ltd
Original Assignee
Tanabe Seiyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co Ltd filed Critical Tanabe Seiyaku Co Ltd
Publication of AU2001295915A1 publication Critical patent/AU2001295915A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
AU2001295915A 2000-10-12 2001-10-11 Method of forming polypeptide particles Abandoned AU2001295915A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000-312167 2000-10-12
JP2000312167 2000-10-12
PCT/JP2001/008911 WO2002030449A1 (en) 2000-10-12 2001-10-11 Method of forming polypeptide particles

Publications (1)

Publication Number Publication Date
AU2001295915A1 true AU2001295915A1 (en) 2002-04-22

Family

ID=18791811

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001295915A Abandoned AU2001295915A1 (en) 2000-10-12 2001-10-11 Method of forming polypeptide particles

Country Status (7)

Country Link
US (1) US20040039171A1 (en)
EP (1) EP1338287A1 (en)
KR (1) KR20030040532A (en)
CN (1) CN1469753A (en)
AU (1) AU2001295915A1 (en)
CA (1) CA2424069A1 (en)
WO (1) WO2002030449A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10029201A1 (en) * 2000-06-19 2001-12-20 Basf Ag Retarded release oral dosage form, obtained by granulating mixture containing active agent and polyvinyl acetate-polyvinyl pyrrolidone mixture below the melting temperature
US20050142205A1 (en) * 2003-07-18 2005-06-30 Julia Rashba-Step Methods for encapsulating small spherical particles prepared by controlled phase separation
SG135204A1 (en) * 2003-07-18 2007-09-28 Baxter Int Methods for fabrication, uses and compositions of small spherical particles prepared by controlled phase separation
WO2005112893A1 (en) * 2004-05-12 2005-12-01 Baxter International Inc. Microspheres comprising protein and showing injectability at high concentrations of said agent
CN104109250B (en) 2008-05-21 2017-04-12 东丽株式会社 Method For Producing Polymer Fine Particle
CN108553689B (en) * 2018-04-13 2020-03-27 浙江大学 Silk fibroin porous microsphere with nanofiber microstructure and preparation method thereof
CN114002269B (en) * 2021-11-01 2023-11-24 杭州电子科技大学 polypeptide/MoS 2 /SnO 2 Preparation method and application of composite material

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5478564A (en) * 1990-02-22 1995-12-26 Teva Pharmaceutical Industries, Ltd. Preparation of microparticles for controlled release of water-soluble substances
ES2110573T3 (en) * 1992-08-07 1998-02-16 Takeda Chemical Industries Ltd PRODUCTION OF MICROCAPSULES OF DRUGS SOLUBLE IN WATER.
JP4308933B2 (en) * 1997-12-12 2009-08-05 あすか製薬株式会社 Microsphere formulation containing dolastatin 10 derivative
JPH11302156A (en) * 1998-04-16 1999-11-02 Tanabe Seiyaku Co Ltd Atomization of polypeptide

Also Published As

Publication number Publication date
EP1338287A1 (en) 2003-08-27
CA2424069A1 (en) 2002-04-18
WO2002030449A1 (en) 2002-04-18
KR20030040532A (en) 2003-05-22
US20040039171A1 (en) 2004-02-26
CN1469753A (en) 2004-01-21

Similar Documents

Publication Publication Date Title
AU2002255719A1 (en) Method for manufacture of fine particles
AU2001240115A1 (en) Method for the preparation of tetrahydrobenzothiepines
AU2002364528A1 (en) Bio-implant and method of making the same
AU2001294175A1 (en) Method of purifying antibody
AU2001245928A1 (en) Electrolyzer and method of using the same
AU2001265390A1 (en) Method of making electronic materials
AU2002248236A1 (en) Method of forming nano-crystalline particles and produrct formed thereof
AU2001241075A1 (en) Method of anticipating interaction between proteins
AU2001266979A1 (en) New magnetic materials, metallic particles and method of making same
AU2001260774A1 (en) Bio-support and preparing method of the same
AU2001295450A1 (en) Method of polypeptide renaturation
AU2534899A (en) An improved method of fabricating coded particles
AU2001295915A1 (en) Method of forming polypeptide particles
AU2002228801A1 (en) Post-crepe stabilized material and method of producing the same
AU3083400A (en) Method of magnetically separating particulate materials
AU2002354363A1 (en) Method of activating protein
AU2002354954A1 (en) Polymer-matrix materials and methods for making same
AU2001274004A1 (en) Method for the production of 2- coumarone and substituted 2-coumarones
AU2001254995A1 (en) Method of manufacturing particles
AU2002364340A1 (en) High-porosity materials and method for preparing same
AU2002213954A1 (en) Method for the selective modification of peptides and proteins
AU2001234307A1 (en) Method for the positioning of macromolecules and particles
AU1106801A (en) Method of preparing metal oxide particles
AU2001286268A1 (en) Method of forming complex
AU4157800A (en) Method for the preparation of particles